Severe skin toxicity in pediatric oncology patients treated with voriconazole and concomitant methotrexate

Johan G.C. Van Hasselt, Natasha K.A. Van Eijkelenburg, Alwin D.R. Huitema, Jan H.M. Schellens, Antoinette Y.N. Schouten-Van Meeteren

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)

Abstract

We report the occurrence of skin toxicities in pediatric oncology patients on concomitant treatment with voriconazole and methotrexate (MTX). Of 23 patients who received this combination, 11 patients suffered from cheilitis and/or photosensitivity. In contrast, only in 1 of 9 patients who received voriconazole without MTX was photosensitivity observed. A mechanism of action was not able to be identified. We describe two cases with severe skin toxicities. Caution is warranted when using voriconazole and concomitant MTX.

Original languageEnglish
Pages (from-to)2878-2881
Number of pages4
JournalAntimicrobial Agents and Chemotherapy
Volume57
Issue number6
DOIs
Publication statusPublished - Jun 2013
Externally publishedYes

Fingerprint

Dive into the research topics of 'Severe skin toxicity in pediatric oncology patients treated with voriconazole and concomitant methotrexate'. Together they form a unique fingerprint.

Cite this